Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction

Thrombosis Research

Volumn 121, Issue 3, 2007, Pages 293-299

  Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Garcia Gonzalez, Martín J ^a   Kaski, Juan Carlos ^c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Interleukin 10; Soluble CD40 ligand; ST segment elevation myocardial infarction

Indexed keywords

CD40 LIGAND; INTERLEUKIN 10;

AGED; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CD40 LIGAND; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SOLUBILITY;

EID: 37749015318     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.04.007     Document Type: Article

References (36)

1. Ross R. Atherosclerotic: an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Lindmark E., Wallentin L., and Siegbahn A. Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease. Thromb Res 103 (2001) 249-259
3. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169 (2003) 203-214
4. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-879
5. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., and Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394 (1998) 200-203
6. Schonbeck U., and Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58 (2001) 4-43
7. Henn V., Slupsky J.R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391 (1998) 591-594
8. Graf D., Muller S., Korthauer U., van Kooten C., Weise C., and Kroczek R.A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25 (1995) 1749-1754
9. Henn V., Steinbach S., Buchner K., Presek P., and Kroczek R.A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98 (2001) 1047-1054
10. de Vries J.E. Immunosuppressive and anti-inflammatory properties of interleukin-10. Ann Med 27 (1995) 537-541
11. Mills R., and Bhatt D.L. The Yin and Yang of arterial inflammation. J Am Coll Cardiol 44 (2004) 50-52
12. Heeschen C., Dimmeler S., Hamm C.W., van den Brand M.J., Boersma E., Zeiher A.M., et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348 (2003) 1104-1111
13. Varo N., de Lemos J.A., Libby P., Morrow D.A., Murphy S.A., Nuzzo R., et al. Soluble CD40L risk prediction after acute coronary syndromes. Circulation 108 (2003) 1049-1052
14. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the antiinflamatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
15. Tziakas DN, Chalikias GK, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA, Tentes IK, Kortsaris AX, Hatseras DI. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: A factor analysis approach. Atherosclerosis in press.
16. Chalikias G.K., Tziakas D.N., Kaski J.C., Kekes A., Hatzinikolaou E.I., Stakos D.A., Tentes I.K., Kortsaris A.X., and Hatseras D.I. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Int J Cardiol 117 (2007) 333-339
17. Myocardial infarction redefined - a consensus of the Join European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 21 (2000) 1502-1513
18. Miller J.M., Smalling R., Ohman E.M., Bode C., Betriu A., Kleiman N.S., et al. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Am J Cardiol 84 (1999) 779-784
19. Killip T., and Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 20 (1967) 457-464
20. Mahajan N., Mehta Y., Rose M., Shani J., and Lichstein E. Elevated troponin level is not synonymous with myocardial infarction. Int J Cardiol 111 (2006) 442-449
21. Setsuta K., Seino Y., Takahashi N., Ogawa T., Sasaki K., Harada A., et al. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 84 (1999) 608-611
22. Hamm C.W. Acute coronary syndromes. The diagnostic role of troponins. Thromb Res 103 Suppl 1 (2001) S63-S69
23. Emond M., Mock M.B., Davis K.B., Fisher L.D., Holmes Jr. D.R., Chaitman B.R., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 90 (1994) 2645-2657
24. Brezinski D., Stone P.H., Muller J.E., Tofler G.H., Davis V., Parker C., et al. Prognostic significance of the Karnofsky performance status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance. The MILIS study group. Am Heart J 121 (1991) 1374-1381
25. Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., and Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100 (1999) 793-798
26. Mach F., Schonbeck U., Bonnefoy J.Y., Pober J.S., and Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 96 (1997) 396-399
27. Urbich C., Mallat Z., Tedgui A., Clauss M., Zeiher A.M., and Dimmeler S. Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation. J Clin Invest 108 (2001) 1451-1458
28. Andre P., Prasad K.S., Denis C.V., He M., Papalia J.M., Hynes R.O., et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med 8 (2002) 247-252
29. Mason P.J., Chakrabarti S., Albers A.A., Rex S., Vitseva O., Varghese S., et al. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Am J Cardiol 96 (2005) 1365-1369
30. Perez Fernandez R., and Kaski J.C. Interleukin-10 and coronary disease. Rev Esp Cardiol 55 (2002) 738-750
31. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-755
32. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107 (2003) 2998-3002
33. Waehre T., Halvorsen B., Damas J.K., Yndestad A., Brosstad F., Gullestad L., et al. Inflammatory imbalance between IL-10 and TNF-α in unstable angina potential plaque stabilizing effects of IL-10. Eur J Clin Invest 32 (2002) 803-810
34. Uyemura K., Demer L.L., Castle S.C., Jullien D., Berliner J.A., Gately M.K., et al. Cross regulatory roles of interleukin-12 and interleukin-10 in atherosclerosis. J Clin Invest 97 (1996) 2130-2138
35. Chalikias G.K., Tziakas D.N., Kaski J.C., Hatzinikolaou E.I., Stakos D.A., Tentes I.K., et al. Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome. Atherosclerosis 182 (2005) 135-143
36. Kilic T., Ural D., Ural E., Yumuk Z., Agacdiken A., Sahin T., et al. Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Heart 92 (2006) 1041-1046